Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody

Under the agreement, Kali Therapeutics is set to receive $180m in upfront and near-term payments.

Latest news

Monash University and ClinChoice partner on new therapies development

The partnership aims to speed up early-phase clinical development and provide new therapies to patients.

Earendil Labs lands $787m to fund biologics development push

Backed by partner Sanofi, Earendil will expand the utility of its AI-driven drug discovery platform, while progressing its more than 40-strong drug pipeline.

Novartis to acquire SNV4818 from Synnovation

SNV4818 is an oral drug and is presently being assessed in an ongoing Phase I/II trial for breast cancer.

Novo Nordisk’s Wegovy HD secures FDA greenlight amid patent expiries

Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it vulnerable to biosimilar competition in these regions.

Navigating the valley of death: a how-to from an investor’s perspective

At Advanced Therapies, investors noted that early planning, adaptability and building trust will help a biotech startup succeed.